Alina Efremenko - Concepedia

Author

Alina Efremenko

The Hamner Institutes for Health Sciences ORCID

Also Known As

A. Efremenko, A. Y. Efremenko, A.Y. Efremenko, Alina Efremenko, Alina Y Efremenko, Alina Y. Efremenko

Publications

439

Citations

H-Index

Concepts

All Affiliations

The Hamner Institutes for Health Sciences Triangle Research Triangle Park Foundation Syngenta (United States)University of Surrey

About

Alina Efremenko is an author at The Hamner Institutes for Health Sciences specializing in medicine, toxicology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	297
2	Health Sciences	3	3	110
3	Public Health	3	3	63
4	Allergy	2	2	44
5	Management	1	1	33

Alina Efremenko

Publications

403

Citations

H-Index

Page 1

	Year	Citations
Evaluation of simple in vitro to in vivo extrapolation approaches for environmental compounds Miyoung Yoon, Alina Efremenko, Bas J. Blaauboer, Toxicology in Vitro Preclinical Drug EvaluationBiochemistryExcipientsMedicineEnvironmental Analytical Chemistry	2013	56
New framework for a non-animal approach adequately assures the safety of cosmetic ingredients – A case study on caffeine Dagmar Bury, Camilla Alexander‐White, Harvey J. Clewell, Regulatory Toxicology and Pharmacology Dietary ExposureDermatologyPhysiologically-based Pharmacokinetic ModelingFood ToxicologyNon-animal Approach	2021	48
Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans Pankajini Mallick, Marjory Moreau, Gina Song, Toxicological Sciences Internal DosePharmacotherapyIntrinsic ClearancePhysiologically-based Pharmacokinetic ModelingPharmacokinetics	2019	47
Profiling Dose-Dependent Activation of p53-Mediated Signaling Pathways by Chemicals with Distinct Mechanisms of DNA Damage Rebecca A. Clewell, Bin Sun, Yeyejide Adeleye, Toxicological Sciences Dna DamageMolecular BiologyCell DeathToxicological MechanismP53 Activation	2014	43
Application of a combined aggregate exposure pathway and adverse outcome pathway (AEP-AOP) approach to inform a cumulative risk assessment: A case study with phthalates Rebecca A. Clewell, Jeremy A. Leonard, Chantel I. Nicolas, Toxicology in Vitro Environmental HealthRisk ManagementHealth Risk AssessmentManagementExposure Assessment	2020	33
Evaluation of gene expression changes in human primary uroepithelial cells following 24‐Hr exposures to inorganic arsenic and its methylated metabolites Janice W. Yager, P. Robinan Gentry, Russell S. Thomas, Environmental and Molecular Mutagenesis	2012	28
Transcriptional responses in the rat nasal epithelium following subchronic inhalation of naphthalene vapor Harvey J. Clewell, Alina Efremenko, Jerry L. Campbell, Toxicology and Applied Pharmacology AsthmaSignal TransductionAllergyInflammatory Lung DiseaseLung Inflammation	2014	27
Evaluation of Age-Related Pyrethroid Pharmacokinetic Differences in Rats: Physiologically-Based Pharmacokinetic Model Development Using In Vitro Data and In Vitro to In Vivo Extrapolation Gina Song, Marjory Moreau, Alina Efremenko, Toxicological Sciences AgingPharmacotherapyExperimental PharmacologyPhysiologically-based Pharmacokinetic ModelingPharmacological Study	2019	22
Population Life-course exposure to health effects model (PLETHEM): An R package for PBPK modeling Salil N. Pendse, Alina Efremenko, C. Eric Hack, Computational Toxicology R PackagePopulation ScienceHealth EffectPopulation ExposureEnvironmental Health	2019	19
Time- and concentration-dependent genomic responses of the rat airway to inhaled nickel subsulfide Alina Efremenko, Jerry L. Campbell, Darol E. Dodd, Toxicology and Applied Pharmacology AllergyRespiratory ToxicologyPhysiologyPulmonary PharmacologyToxicology	2014	17

Page 1